Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Whitcup

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 24, 2004
Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbitsJennifer Q Dong, Darius M Babusis, Devin F Welty, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 9, 2002
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertensionEve J Higginbotham, Joel S Schuman, Ivan Goldberg, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Topical cyclosporine versus emulsion vehicle for the treatment of brittle nails: a randomized controlled pilot studyJulian Mackay-Wiggan, Jackleen Marji, John G Walt, et al.
Ophthalmology Science|June 17, 2024
A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent PterygiumScott M Whitcup, Kenneth N Sall, John A Hovanesian, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 10, 2010
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edemaJulia A Haller, Baruch D Kuppermann, Mark S Blumenkranz, et al.
BMC Ophthalmology|November 1, 2015
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD studyAlbert J Augustin, Baruch D Kuppermann, Paolo Lanzetta, et al.
Investigative Ophthalmology & Visual Science|August 13, 2010
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implantJoan-En Chang-Lin, Mayssa Attar, Andrew A Acheampong, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 13, 2006
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trialMark B Sherwood, E Randy Craven, Connie Chou, et al.
American Journal of Ophthalmology|March 10, 2009
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndromeGeorge A Williams, Julia A Haller, Baruch D Kuppermann, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 14, 2007
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edemaBaruch D Kuppermann, Mark S Blumenkranz, Julia A Haller, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 24, 2004
Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbitsJennifer Q Dong, Darius M Babusis, Devin F Welty, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 9, 2002
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertensionEve J Higginbotham, Joel S Schuman, Ivan Goldberg, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Topical cyclosporine versus emulsion vehicle for the treatment of brittle nails: a randomized controlled pilot studyJulian Mackay-Wiggan, Jackleen Marji, John G Walt, et al.
Ophthalmology Science|June 17, 2024
A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent PterygiumScott M Whitcup, Kenneth N Sall, John A Hovanesian, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 10, 2010
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edemaJulia A Haller, Baruch D Kuppermann, Mark S Blumenkranz, et al.
BMC Ophthalmology|November 1, 2015
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD studyAlbert J Augustin, Baruch D Kuppermann, Paolo Lanzetta, et al.
Investigative Ophthalmology & Visual Science|August 13, 2010
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implantJoan-En Chang-Lin, Mayssa Attar, Andrew A Acheampong, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 13, 2006
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trialMark B Sherwood, E Randy Craven, Connie Chou, et al.
American Journal of Ophthalmology|March 10, 2009
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndromeGeorge A Williams, Julia A Haller, Baruch D Kuppermann, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 14, 2007
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edemaBaruch D Kuppermann, Mark S Blumenkranz, Julia A Haller, et al.
Pageof 7